SMTL ID : 3w1w.1

Protein-drug complex

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.01 Å

Oligo State

homo-dimer

Ligands

2 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)

FES.1: 7 residues within 4Å: Chain A: C.144, R.220, S.350, C.351, C.354, C.359 Ligands: EDO.6 4 PLIP interactions: 4 interactions with chain A, Metal complexes: A:C.144, A:C.351, A:C.354, A:C.359 FES.8: 7 residues within 4Å: Chain B: C.144, R.220, S.350, C.351, C.354, C.359 Ligands: EDO.12 4 PLIP interactions: 4 interactions with chain B, Metal complexes: B:C.144, B:C.351, B:C.354, B:C.359

8 x CHD: CHOLIC ACID(Non-covalent)

CHD.2: 13 residues within 4Å: Chain A: M.24, L.40, F.41, L.46, M.47, I.67, S.145, H.211, P.214, V.217, V.253, W.258 Ligands: CHD.3 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:L.40, A:L.40, A:F.41, A:L.46, A:V.253, A:V.253, A:W.258 Hydrogen bonds: A:S.145, A:S.145, A:E.291 Water bridges: A:Q.70, A:Q.70, A:Q.70, A:H.211, A:R.220, A:S.251, A:E.291 CHD.3: 10 residues within 4Å: Chain A: M.47, I.59, R.62, L.63, V.253, G.254, M.256, W.258 Ligands: CHD.2, CHD.4 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:M.47, A:I.59, A:L.63, A:V.253, A:W.258 Salt bridges: A:R.62 CHD.4: 7 residues within 4Å: Chain A: T.48, L.49, P.50, L.55, I.59, R.62 Ligands: CHD.3 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:P.50 CHD.7: 5 residues within 4Å: Chain A: T.348, R.360, K.363 Chain B: G.274, R.275 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:K.363 Water bridges: A:R.360, A:R.360 CHD.9: 12 residues within 4Å: Chain B: M.47, I.59, R.62, L.63, P.214, S.216, V.253, G.254, M.256, W.258 Ligands: CHD.10, CHD.11 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:M.47, B:I.59, B:P.214, B:W.258 Hydrogen bonds: B:S.216, B:S.216 Water bridges: B:V.253, B:G.254 Salt bridges: B:R.62 CHD.10: 5 residues within 4Å: Chain B: T.48, L.49, P.50, L.55 Ligands: CHD.9 4 PLIP interactions: 4 interactions with chain B Hydrophobic interactions: B:L.49, B:P.50, B:L.55 Water bridges: B:T.48 CHD.11: 14 residues within 4Å: Chain B: M.24, L.40, F.41, L.46, I.67, Q.70, S.145, H.211, P.214, V.217, V.253, W.258, E.291 Ligands: CHD.9 13 PLIP interactions: 13 interactions with chain B Hydrophobic interactions: B:F.41, B:L.46, B:V.253, B:V.253, B:W.258 Hydrogen bonds: B:S.145, B:E.291 Water bridges: B:Q.70, B:Q.70, B:H.211, B:R.220, B:S.251, B:E.291 CHD.13: 5 residues within 4Å: Chain A: G.274, R.275 Chain B: T.348, R.360, K.363 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:K.363 Water bridges: B:S.364

1 x SAL: 2-HYDROXYBENZOIC ACID(Non-covalent)

SAL.5: 11 residues within 4Å: Chain A: V.218, P.225, Q.226, S.229, W.249, L.259 Chain B: P.225, Q.226, S.229, W.249, L.259 7 PLIP interactions: 5 interactions with chain A, 2 interactions with chain B Hydrophobic interactions: A:P.225, A:W.249, A:L.259, B:P.225 Hydrogen bonds: A:S.229, B:S.229 Water bridges: A:Q.226

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.6: 9 residues within 4Å: Chain A: D.45, C.144, G.148, S.149, N.152, R.220, N.356, C.359 Ligands: FES.1 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:N.356 Water bridges: A:L.46, A:R.220 EDO.12: 9 residues within 4Å: Chain B: D.45, C.144, G.148, S.149, N.152, R.220, N.356, C.359 Ligands: FES.8 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:G.148, B:N.356 Water bridges: B:L.46, B:R.220

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gupta, V. et al., Salicylic Acid induces mitochondrial injury by inhibiting ferrochelatase heme biosynthesis activity. Mol.Pharmacol. (2013)

Release Date

2013-10-09

Peptides

Ferrochelatase, mitochondrial: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Ferrochelatase, mitochondrial